Profiles of Lewisx-containing Glycoproteins and Glycolipids in Sera of Patients with Adenocarcinoma

Cancer Research

Volumn 50, Issue 5, 1990, Pages 1375-1380

  Singhal, A K ^a   Nudelman, E ^a   Nance, S ^a   Schibig, L ^a   Stroud, M R ^a   Clausen, H ^a   Hakomori, S ^a   Orntoft T F ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; DIAGNOSTIC AGENT; GLYCOLIPID; GLYCOPROTEIN; MONOCLONAL ANTIBODY;

ADENOCARCINOMA; ARTICLE; BLOOD; BLOOD GROUP LEWIS SYSTEM; CANCER STAGING; COLON TUMOR; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; MOLECULAR WEIGHT; PATHOLOGY; BLOOD LEVEL; CANCER PATIENT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADENOCARCINOMA; ANTIBODIES, MONOCLONAL; ANTIGENS; COLONIC NEOPLASMS; GLYCOLIPIDS; GLYCOPROTEINS; HUMAN; LEWIS BLOOD-GROUP SYSTEM; MOLECULAR WEIGHT; NEOPLASM STAGING; SUPPORT, NON-U.S. GOV'T;

EID: 0025192882     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Yang, H-J., and Hakomori, S. A sphingolipid having a novel type of ceramide and lacto-N-fucopentaose III. J. Biol. Chem., 246:1192–1200, 1971.
2. Hakomori, S., Nudelman, E., Levery, S. B., and Kannagi, R. Novel fucolipids accumulating in human adenocarcinoma: I. Glycolipids with di- or trifuco-sylated type 2 chain. J. Biol. Chem., 259:4672–4680, 1984.
3. Koprowski, H., Herlyn, M., Steplewski, Z., and Sears, H. F. Specific antigen in serum of patients with colon carcinoma. Science (Wash. DC), 212:53–55, 1981.
4. Magnani, J. L., Nilsson, B., Brockhaus, M., Zopf, D., Steplewski, Z., Koprowski, H., and Ginsburg, V. A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II. J. Biol. Chem., 257: 14365–14369, 1982.
5. Chia, D., Terasaki, P. I., Suyama, N., Galton, J., Hirota, M., and Katz, D. Use of monoclonal antibodies to sialylated Lewis1 and sialylated Lewis× for serological tests of cancer. Cancer Res., 45:435–437, 1985.
6. Haglund, C., Roberts, P. J., Kuusela, P., Scheinin, T. M., Makela, O., and Jalanko, H. Elevation of CA 19–9 as a serum tumour marker in pancreatic cancer. Br. J. Cancer, 53:197–202, 1986.
7. del Favero, G., Fabris, C., Plebani, M., Panucci, A., Piccoli, A., Perobelli, L., Pedrazzoli, S., Baccaglini, U., Burlina, A., and Naccarato, R. CA 19–9 and carcinoembryonic antigen in pancreatic cancer diagnosis. Cancer (Phila.), 57:1576–1579, 1986.
8. Fukushima, K., Hirota, M., Terasaki, P. I., Wakisaka, A., Togashi, H., Chia, D., Suyama, N., Fukushi, Y., Nudelman, E., and Hakomori, S. Characterization of sialosylated Lewis as a new tumor-associated antigen. Cancer Res., 44: 5279–5285, 1984.
9. Fukushi, Y., Nudelman, E., Levery, S. B., Rauvala, H., and Hakomori, S. Novel fucolipids accumulating in human cancer III. A hybridoma antibody (FH6) defining a human cancer-associated difucoganglioside (VI3NeuAcV3III3Fuc2nLc«). J. Biol. Chem., 259:10511–10517, 1984.
10. Myoga, A., Taki, T., Arai, K., Sekiguchi, K., Ikeda, I., Kurata, K., and Matsumoto, M. Detection of patients with cancer by monoclonal antibody directed to lactoneotetraosylceramide (paragloboside). Cancer Res., 48: 1512–1516, 1988.
11. Rettig, W. J., Cordon-Cardo, C., Ng, J. S. C., Oettgen, H. F., Old, L. J., and Lloyd, K. O. High-molecular-weight glycoproteins of human teratocarcinoma defined by monoclonal antibodies to carbohydrate determinants. Cancer Res., 45:815–821, 1985.
12. Magnani, J. L., Steplewski, Z., Koprowski, H., and Ginsburg, V. Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19–9 in the sera of patients as mucin. Cancer Res., 43: 5489–5492, 1983.
13. Kannagi, R., Fukushi, Y., Tachikawa, T., Noda, A., Shin, S., Shigeta, K., Hiraiwa, N., Fukuda, Y., Inamoto, T., Hakomori, S., and Imura, H. Quantitative and qualitative characterization of human cancer-associated serum glycoprotein antigens expressing fucosyl of sialyl-fucosyl type 2 chain poly-lactosamine. Cancer Res., 46: 2619–2626, 1986.
14. Kannagi, R., Kitahara, A., Itai, S., Zenita, K., Shigeta, K., Tachikawa, T., Noda, A., Hirano, H., Abe, M., Shin, S., Fukushi, Y., Hakomori, S., and Imura, H. Quantitative and qualitative characterization of human cancer-associated serum glycoprotein antigens expressing epitopes consisting of sialyl- or sialyl-fucosyl type 1 chain. Cancer Res., 48: 3856–3863, 1988.
15. Fukushi, Y., Hakomori, S., and Shepard, T. Localization and alteration of mono-, di-, and trifucosylal–>3 type 2 chain structures during human em-bryogenesis and in human cancer. J. Exp. Med., 159: 506–520, 1984.
16. Herlyn, M., Sears, H. F., Verrill, H., and Koprowski, H. Increased sensitivity in detecting tumor-associated antigens in sera of patients with colorectal carcinoma. J. Immunol. Methods, 75:15–21, 1984.
17. Jolley, M. E., Wang, C-H. J., Ekenberg, S. J., Zuelke, M. S., and Kelso, D. M. Particle concentration fluorescence immunoassay (PCFIA): a new, rapid immunoassay technique with high sensitivity. J. Immunol. Methods, 67:21–35, 1984.
18. Bentzen, S. M., Balslev, I., Pedersen, M., Teglbjaerg, P. S., Hanberg-Soeren-sen, F., Bone, J., Jacobsen, N. O., Overgaard, JM Sell, A., Bertelsen, K., Hage, E., Fenger, C., Kronborg, O., Hansen, L., Hoestrup, H., and Noer-gaard-Pedersen, B. A regression analysis of prognostic factors after resection of Duke's B and C carcinoma of the rectum and rectosigmoid: does postoperative radiotherapy change the prognosis? Br. J. Cancer, 58: 195–201, 1988.
19. Magnani, J. L., Smith, D. F., and Ginsburg, V. Detection of gangliosides that bind cholera toxin: direct binding of l2sI-labeled toxin to thin-layer chromatograms. Anal. Biochem., 109: 399–402, 1980.
20. Fukushi, Y., Hakomori, S., Nudelman, E., and Cochran, N. Novel fucolipids accumulating in human adenocarcinoma: II. Selective isolation of hybridoma antibodies that differentially recognize mono-, di-, and trifucosylated type 2 chain. J. Biol. Chem., 259:4681–4685, 1984.
21. Hakomori, S. Glycosphingolipids in cellular interaction, differentiation, and oncogenesis. Annu. Rev. Biochem., 50:733–764, 1981.
22. Hakomori, S., and Kannagi, R. Glycosphingolipids as tumor-associated and differentiation markers. J. Natl. Cancer Inst., 71:231–251, 1983.
23. Prieels, J-P., Pizzo, S. V., Glasgow, L. R., Paulson, J. C., and Hill, R. S. Hepatic receptor that specifically binds oligosaccharides containing αl→3 N-acetylglucosamine linkages. Proc. Natl. Acad. Sci. USA, 75: 2215–2219, 1978.
24. Tanabe, T., Prior, W. E., and Ashwell, S. Subcellular membrane topology and turnover of a rat hepatic binding protein specific for asialoglycoproteins. J. Biol. Chem., 249: 5536–5543, 1974.
25. Sears, H. F., Herlyn, M., Del Villano, B., Steplewski, Z., and Koprowski, H. Monoclonal antibody detection of a circulating tumor-associated antigen: II. A longitudinal evaluation of patients with colorectal cancer. J. Clin. Immunol., 2:141–149, 1982.